The Sarcopenia Treatment Market is expected to witness an escalation going forward. With health apps, biosensors, AI, VR, telehealth, robots, cloud computing, predictive analysis, and EHRs being rampantly used, there is nothing to hold the healthcare vertical from soaring high. The healthcare vertical, would, see its cash registers ringing on the count of digital IoT creeping in at a rapid pace.
According to the latest market report published by the company titled ‘Sarcopenia Treatment Market: Global Industry Analysis 2013 – 2017 and Forecast, 2018 – 2026,’ the global sarcopenia treatment market is projected to reach US$ 3,302.0 Mn by the end of 2026 and grow at a CAGR of 4.2% during the forecast period.
How About Looking Through The Sample Of Sarcopenia Treatment Market Report? https://www.persistencemarketresearch.com/samples/15694
Global Sarcopenia Treatment Market: Dynamics
Sarcopenia is categorized by progressive and generalized loss of skeletal muscle mass and strength, with a risk of adverse outcomes such as poor quality of life, physical disability and death. Sarcopenia is the age-related loss of muscle mass, after the age of 60 the muscle mass declines at an annual rate of 1.5% to 3.0% per year. The prevalence of sarcopenia among people aged 65 years and above is estimated to be 15%, whereas 50% among people aged 80 and above.
- Abbott Laborites
- Pfizer Inc.
- Novartis AG
- GlaxoSmithKline Plc.
- Nestlé S.A.
- Bayer AG
- Sanofi S.A.
- Cadila Healthcare Ltd.
- Eli Lilly and Company
Get A Customized Scope To Match Your Need Ask An Expert – firstname.lastname@example.org
Increasing consumption of dietary and nutritional supplements due to health consciousness among the elderly population is expected to propel the demand for sarcopenia treatment. The benefits of nutritional supplements to overcome vitamin deficiency is expected to boost the growth of the sarcopenia treatment market.
Most of the pharmaceutical and food-processing companies are investing in the development of new nutrition supplements in order to focus on the specific needs. Likewise, increasing investments in nutraceutical development is the major factor expected to spur the growth of the sarcopenia treatment market.
How About Step-By-Step Insights To Sarcopenia Treatment Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.com/methodology/15694
The growth of the sarcopenia treatment market is primary driven by the increasing aging population. According to the National Institutes of Health (NIH), the global population of people aged 80 and above is expected to grow from 126.5 million to 446.6 million between 2015 and 2050.
Reduction of hormone secretion rate and increasing vitamin deficiency with aging are expected to create high demand for sarcopenia treatment supplements. Economic factors such as the rise in consumer spending by the aging population and increasing per capita healthcare expenditure are also expected to drive the demand for sarcopenia treatment supplements.
According to the National Health Expenditure Accounts (NHEA), the U.S. health care spending grew by 4.3% in 2016, reaching US$ 3.3 trillion or US$ 10,348 per person.
However, the diagnosis rate of sarcopenia is very low as a large number of people ignore the symptoms of muscle loss. Moreover, low awareness regarding diagnostic and management methods of sarcopenia due to lack of skilled professionals is expected to hamper the growth of the sarcopenia treatment market.
Moreover, unavailability of sarcopenia treatment drugs and the high cost of protein supplement are the other factors expected to restrain the growth of the sarcopenia treatment market.
Global Sarcopenia Treatment Market: Forecast
The global sarcopenia treatment market is segmented based on treatment type, distribution channel, and region. Based on treatment type, the global sarcopenia treatment market is segmented into protein supplement, vitamin D & calcium supplement, and vitamin B12 supplement.
The protein supplement segment is expected to represent a high revenue share in the global sarcopenia treatment market over the forecast period.
Based on the distribution channel, the global sarcopenia treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and hypermarket & supermarket. Among all the distribution channels, the retail pharmacies is expected to be the leading segment in the global sarcopenia treatment market over the forecast period.
The online pharmacies segment is expected to represent a high growth rate in the global sarcopenia treatment market due to increasing online purchasing and manufacturer’s inclination towards digital platforms for marketing and sale.
On the basis of region, the global sarcopenia treatment market has been segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
Want To Keep A Tab On The Latest Findings In The Sarcopenia Treatment Market? Purchase Our Sarcopenia Treatment Market Report Now! https://www.persistencemarketresearch.com/checkout/15694
This report assesses the trends driving the growth of each segment and offers analysis and insights into the potential of the sarcopenia treatment in specific regions. North America is expected to contribute a high revenue share in the global sarcopenia treatment market over the forecast period.
The demand for sarcopenia treatment has increased in North America due to the increasing adoption of nutritional supplements, particularly by the elderly population due to increasing health consciousness. Europe is expected to account second large share in the global sarcopenia treatment market over the forecast period.
The developed European countries, such as Germany, the U.K., France, and Italy, are expected to account high share in the Europe sarcopenia treatment market due to increasing sarcopenia prevalence associated with inactive lifestyle and obesity. The Asia Pacific is expected to witness rapid growth in the global sarcopenia treatment market over the forecast period due to increasing aging population in countries such as Japan.
Read More Trending “PMR Exclusive Article”-
Allergy Shots Market–Allergy Shots Market Segmented By SLIT Tablets, Oral, Injections Product with Sublingual Immunotherapy, Subcutaneous Immunotherapy with Allergic Rhinitis, Allergic Asthma, Food Allergy, Atopic Dermatitis indication
Active Pharmaceutical Ingredients Market–Active Pharmaceutical Ingredients Market Segmented By Small Molecules, Non-Controlled Substances, HPAPI, Peptides and Oligonucleotides, Carbohydrate Drugs, Steroidal Drugs API Type
About Us: – Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – email@example.com
Website – https://www.persistencemarketresearch.com